Seattle Genetics COO taking the reins at stealthy biotech startup Silverback Therapeutics – GeekWire

GeekWire
Eric Dobmeier will lead stealthy startup Silverback Therapeutics as its new CEO. (Seattle Genetics Photo). Eric Dobmeier, the longtime COO at public biotech company Seattle Genetics, is stepping down from his role to become CEO at stealthy biotech

and more

…read more

Source:: Startup Tech News From Google News

Leave a Comment